1. Home
  2. TMDE vs BOLD Comparison

TMDE vs BOLD Comparison

Compare TMDE & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TMDE

TMD Energy Limited Ordinary Shares

SELL

Current Price

$1.43

Market Cap

21.7M

Sector

Energy

ML Signal

SELL

Logo Boundless Bio Inc.

BOLD

Boundless Bio Inc.

HOLD

Current Price

$1.14

Market Cap

25.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMDE
BOLD
Founded
2016
2018
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
21.7M
25.7M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
TMDE
BOLD
Price
$1.43
$1.14
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.00
AVG Volume (30 Days)
6.1M
57.3K
Earning Date
01-01-0001
06-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.47
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$0.96
52 Week High
$4.77
$1.78

Technical Indicators

Market Signals
Indicator
TMDE
BOLD
Relative Strength Index (RSI) 47.48 52.62
Support Level $0.69 $1.15
Resistance Level $2.75 $1.19
Average True Range (ATR) 0.69 0.03
MACD -0.10 0.00
Stochastic Oscillator 17.35 75.00

Price Performance

Historical Comparison
TMDE
BOLD

About TMDE TMD Energy Limited Ordinary Shares

TMD Energy Ltd is engaged in marine fuel bunkering services specializing in the supply and marketing of marine gas oil and marine fuel oil (including high sulfur fuel oil, low sulfur fuel oil and very low sulfur fuel oil), to ships and vessels at sea. It is also involved in the provision of ship management services for in-house and external vessels, as well as vessel chartering. It is currently operating with a fleet of nearly 15 bunkering vessels ranging from 540 dwt to 7,820 dwt, of which nearly nine (9) are double bottom and double hull vessels with an average cargo-carrying capacity of approximately 4,200 dwt each.

About BOLD Boundless Bio Inc.

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: